WAGNER CHARLES F JR (EVP and CFO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/26/2026ACC: 0000875320-26-000028
Officer· EVP and CFO
Since Apr 2019
+13.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
13.60K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.44K
Price / share
—
Trade value
—
% of position
25.0%
1/22/2026
37.73K→47.16K
Common Stock
Direct
Shares
+4.16K
Price / share
—
Trade value
—
% of position
8.8%
1/22/2026
47.16K→51.33K
Total
Net shares
+13.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | A · Award | +9.44K | — | — | 25.0% | 37.73K | 47.16K |
| Common Stock Direct | 1/22/2026 | A · Award | +4.16K | — | — | 8.8% | 47.16K | 51.33K |
| Total | +13.60K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported